|
DNA | Ginkgo Bioworks Holdings, Inc. |
|
|
DNA | Ginkgo Bioworks Holdings, Inc. |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ 0.07 |
| Leverage | 48.63% |
| Market Cap | $ 29.9B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -470.9m |
| Margin | -200.21% |
None